61748-015 : Rifampin 150 mg Oral Capsule


NDC61748-015
Labeler: Versapharm Incorporated
Product Type: Human Prescription Drug
Drug Name:  Rifampin
Dosage Form: Oral Capsule, Coated
Application #: ANDA065028
Rev. Date: 


Appearance:


Markings: Rifampin;150;VP;015
Shapes:  Capsule
Colors:  Orange
Size (mm): 18
Segments: * 1

* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 1 indicates a solid pill with no score lines.

Rifampin 150 VP 015: (61748-015) Rifampin 150 mg Oral Capsule by Versapharm Incorporated
The above image is provided by the U.S. National Library of Medicine (NLM) and is not part of the official label.

NDC Package Codes:

  • 61748-015-11: 100 CAPSULE, COATED IN 1 BOX, UNIT‑DOSE (61748‑015‑11)
  • 61748-015-30: 30 CAPSULE IN 1 BOTTLE, PLASTIC (61748‑015‑30)

Active Ingredients:

  • Rifampin

Dosage Strength:

  • 150 mg

Inactive Ingredients:

  • Lactose Monohydrate
  • Sodium Lauryl Sulfate
  • Talc
  • Starch, Corn
  • Silicon Dioxide
  • Magnesium Stearate
  • Ammonia
  • Isopropyl Alcohol
  • Butyl Alcohol
  • Shellac
  • Propylene Glycol
  • Dimethicone
  • Titanium Dioxide
  • Fd&c Blue No. 1
  • Fd&c Red No. 40
  • Gelatin

Pharmaceutical Classes:

  • Rifamycin Antibacterial [EPC]
  • Rifamycins [Chemical/Ingredient]

Related Products:

Based on records with the same trade name.
  • 61748-018 Rifampin 300 mg Oral Capsule by Versapharm Incorporated
  • 0069-0112 Rifampin 600 mg/10ml Intravenous Injection, Powder, Lyophilized, for Solution by Pfizer Laboratories Div Pfizer Inc
  • 0069-0141 Rifampin 600 mg/10ml Intravenous Injection, Powder, Lyophilized, for Solution by Pfizer Laboratories Div Pfizer Inc
  • 0143-9230 Rifampin 600 mg Intravenous Injection, Powder, Lyophilized, for Solution by West-ward Pharmaceuticals Corp
  • 0185-0799 Rifampin 300 mg Oral Capsule by Eon Labs, Inc.
  • 0185-0801 Rifampin 150 mg Oral Capsule by Eon Labs, Inc.
  • 0527-1315 Rifampin 300 mg Oral Capsule by Lannett Company, Inc.
  • 0527-1393 Rifampin 150 mg Oral Capsule by Lannett Company, Inc.
  • 0904-5282 Rifampin 300 mg Oral Capsule by Major Pharmaceuticals
  • 17478-151 Rifampin 600 mg/10ml Intravenous Injection, Powder, Lyophilized, for Solution by Akorn Inc.
  • 17478-155 Rifampin 600 mg/10ml Intravenous Injection, Powder, Lyophilized, for Solution by Akorn
  • 21695-527 Rifampin 300 mg Oral Capsule by Rebel Distributors Corp
  • 23155-340 Rifampin 600 mg/10ml Intravenous Injection, Powder, Lyophilized, for Solution by Heritage Pharmaceuticals Inc.
  • 24236-202 Rifampin 300 mg by Remedyrepack Inc.
  • 42254-039 Rifampin 300 mg Oral Capsule by Rebel Distributors Corp
  • 49349-250 Rifampin 300 mg Oral Capsule by Remedyrepack Inc.
  • 49349-311 Rifampin 150 mg Oral Capsule by Remedyrepack Inc.
  • 49349-447 Rifampin 150 mg Oral Capsule by Remedyrepack Inc.
  • 50090-0963 Rifampin 300 mg Oral Capsule by A-s Medication Solutions
  • 50090-0964 Rifampin 300 mg Oral Capsule by A-s Medication Solutions
  • More related products ...

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 61748-015 QR Code

< Prev: 61748-014Next: 61748-016 >

Related Discussions:

R Cinex Rifampin And Isoniazid Capsule U P S
I have been taking R Cinex Rifampin And Isoniazid Capsule U P S since last 67 days but I missed 1day dose,which doctor p... 3 replies
Side effects of Rifampin (rifampicin)
Hello, I would like to know if anyone is taking Rifampin and what are side effects, i read about it online but would lik... 1 reply
rifampin 150mg tablet availability
I need to locate the above mentioned medicine. I can not locate this drug in tablet form locally. Can anyone tell me abo...
rifampin
infection...




Notice: The MedsChat® NDC Database compiles publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.


Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 16 July 2015.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA